Follow this link to a listing of SEER SINQ's that have been finalized during the months of August through November 2021.
Highlights of this listing include:
20210043 instructs whether a diagnosis of serous tubal intraepithelial neoplasm (STIN) is equivalent to serous tubal intraepithelial carcinoma (STIC).
20210048 informs if a 2021 diagnosis of moderate squamous dysplasia (AIN II) of the anal canal is reportable.
20210049 advises how to correctly code histology for Acute Myeloid Leukemia (AML) with recurrent genetic abnormalities and provides a correction on how it was previously considered an alternate to 9896/3.
If you have questions or concerns regarding any of the content of this CRGC News Broadcast please contact me.